|
Hernandez-Sanchez A, Villaverde-Ramiro A, Arellano-Rodrigo E, Garrote M, Martin I, Mosquera-Orgueira A, Gomez-Casares MT, Ferrer-Marin F, Such E, Velez P, Ayala R, Angona A, de Las Heras N, Magro E, Mata-Vazquez MI, Fox ML, de Villambrosia SG, Ramirez MJ, Garcia A, Garcia-Gutierrez V, Caceres A, Duran MA, Senin A, Raya JM, Gonzalez JA, Cuevas B, Xicoy B, Perez-Encinas M, Bellosillo B, Alvarez-Larran A, Hernandez-Rivas JM, Hernandez-Boluda JC; Spanish MPN Group (GEMFIN). The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis. Am J Hematol. 2024 Apr;99(4):755-758. doi: 10.1002/ajh.27203. Epub 2024 Jan 30. PubMed PMID: 38291566.
AÑO: 2024; IF: 10.1
|
38291566
|
Garrote M, Lopez-Guerra M, Garcia-Pagan JC, Arellano-Rodrigo E, Ferrer-Marin F, Hernandez-Boluda JC, Bellosillo B, Nomdedeu M, Hernandez-Gea V, Triguero A, Guijarro F, Alamo J, Baiges A, Turon F, Colomer D, Cervantes F, Alvarez-Larran A. Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology. Ann Hematol. 2024 Mar;103(3):737-747. doi: 10.1007/s00277-023-05610-x. Epub 2024 Jan 24. PubMed PMID: 38263537; PubMed Central PMCID: PMC10866782.
AÑO: 2024; IF: 3.0
|
|
Berna-Erro A, Granados MP, Teruel-Montoya R, Ferrer-Marin F, Delgado E, Corbacho AJ, Fenandez E, Vazquez-Godoy MT, Tapia JA, Redondo PC. SARAF overexpression impairs thrombin-induced Ca2+ homeostasis in neonatal platelets. Br J Haematol. 2024 Mar;204(3):988-1004. doi: 10.1111/bjh.19210. Epub 2023 Dec 7. PubMed PMID: 38062782.
AÑO: 2024; IF: 5.1
|
|
Marce S, Mendez A, Xicoy B, Estrada N, Cabezon M, Sturla AL, Garcia MR, Angona A, Amat P, Escribano Serrat S, Scalzulli E, Morgades M, Senin A, Hernandez-Boluda JC, Ferrer-Marin F, Anguita E, Cortes M, Plensa E, Breccia M, Garcia-Gutierrez V, Zamora L; Grupo Espanol de Leucemia Mieloide Cronica (GELMC). e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response. J Clin Med. 2024 Jan 29;13(3):779. doi: 10.3390/jcm13030779. PubMed PMID: 38337473; PubMed Central PMCID: PMC10856594.
AÑO: 2024; IF: 3.0
|
|
Cuenca-Zamora EJ, Martinez C, Morales ML, Guijarro-Carrillo PJ, Lopez-Poveda MJ, Alcolea-Guardiola C, Vidal-Garrido N, Lozano ML, Gonzalez-Conejero R, Teruel-Montoya R, Ferrer-Marin F. Pacritinib prevents inflammation-driven myelofibrosis-like phenotype in a miR-146a-/- murine model. Biomed Pharmacother. 2024 Dec;181:117712. doi: 10.1016/j.biopha.2024.117712. Epub 2024 Nov 26. PubMed PMID: 39603040.
AÑO: 2024; IF: 6.9
|